Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-17

Clinical Trial Update: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pivmecillinam hydrochloride tablets for treating uncomplicated urinary tract infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • pivmecillinam hydrochloride tablets (pivmecillinam hydrochloride)

Snippet

Sponsor: Benova (Tianjin) Innovative medicine Research Co., Ltd. | Conditions: Uncomplicated Urinary Tract Infection | Phase 3 | Status: COMPLETED